Liposome research in drug delivery: The early days

Journal of Drug Targeting

Volumn 16, Issue 7-8, 2008, Pages 520-524

  Gregoriadis, Gregory ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ASIALOGLYCOPROTEIN; DNA VACCINE; DOXORUBICIN; DRUG CARRIER; GALACTOSE; HEPATITIS A VACCINE; INFLUENZA VACCINE; LIPOSOME; LIVER ENZYME; MACROGOL; MICROSPHERE; MONOCLONAL ANTIBODY; PHOSPHOLIPID; POLYCLONAL ANTIBODY; POLYMER; POLYSACCHARIDE; SMALL INTERFERING RNA;

ANTIGEN PRESENTATION; CELL FUSION; CELL MEMBRANE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG HALF LIFE; DRUG RESEARCH; DRUG STABILITY; DRUG STORAGE; DRUG TARGETING; EDITORIAL; HEPATITIS A; HUMAN; INFLUENZA; LIPOSOMAL DELIVERY; LYSOSOME STORAGE DISEASE; MACROMOLECULE; MALIGNANT NEOPLASTIC DISEASE; MATERIAL COATING; MICROCAPSULE; PRIORITY JOURNAL;

DRUG DELIVERY SYSTEMS; HISTORY, 20TH CENTURY; LIPOSOMES; RESEARCH;

EID: 49149118299     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860802228350     Document Type: Editorial

References (36)

1. Allison, AC and Gregoriadis, G. (1974) Liposomes as immunological adjuvants. Nature, 252, p. 252.
2. Alving, CR (1991) Liposomes as carriers of antigens and adjuvants. Immunol Methods, 140, pp. 1-13.
3. Bangham, AD, Standish, MM and Weismann, G. (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol, 13, pp. 238-252.
4. Barenholz, Y. (2007) Liposome technology.pp. 1-25. Informa, New York
5. Blume, G. and Cevc, G. (1990) Liposomes for the sustained drug release in vivo. Biochim Biophys Acta, 1029, pp. 91-97.
6. Cevc, G. and Vierl, U. (2007) Spatial distribution of cutaneous microvasculature and local drug clearance after drug application on the skin. J Control Release, 118, pp. 18-26.
7. Gregoriadis, G. (1973) Drug entrapment in liposomes. FEBS Lett, 36, pp. 292-296.
8. Gregoriadis, G. (1974) Structural requirements for the specific uptake of macromolecules and liposomes by target tissues. Enzyme therapy in lysosomal storage disease, pp. 131-148. North-Holland Publishing Co., Amsterdam
9. Gregoriadis, G. (1976) The carrier potential of liposomes. New Engl J Med, 295, pp. 765-770.
10. Gregoriadis, G. (1992) Liposomes technology, CRC Press, Boca Raton
11. Gregoriadis, G. (1995) Twinkling guide stars to throngs of acolytes desirous of your membrane semi-barriers, precursors of bion, potential drug carriers. J Liposome Res, 5, pp. 329-346.
12. Gregoriadis, G. (2007) Liposome technology, Informa, New York
13. Gregoriadis, G. and Allison, AC (1974) Entrapment of proteins in liposomes prevents allergic reactions in preimmunised mice. FEBS Lett, 45, pp. 71-74.
14. Gregoriadis, G., Bacon, A., McCormack, B., Laing, P., Frisch, B. and Schuber, F. (2007) Liposome-based DNA/protein vaccines: Procedures for entrapment and immunization studies. pp. 233-244. Informa, New York
15. Gregoriadis, G. and Buckland, RA (1973) Enzyme-containing liposomes alleviate a model for storage disease. Nature, 244, pp. 170-172.
16. Gregoriadis, G. and Neerunjun, DE (1975) Treatment of tumour bearing mice with liposome-entrapped actinomycin D prolongs their survival. Res Commun Chem Pathol Pharmacol, 10, pp. 351-362.
17. Gregoriadis, G. and Neerunjun, ED (1975) Homing of liposomes to target cells. Biochem Biophys Res Commun, 65, pp. 537-544.
18. Gregoriadis, G. and Ryman, BE (1972) Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage disease. Eur J Biochem, 24, pp. 485-491.
19. Gregoriadis, G. and Ryman, BE (1972) Lysosomal localization of β-fructofuranosidase-containing liposomes injected into rats. Some implications in the treatment of genetic disorders. Biochem J, 129, p. 123.
20. Gregoriadis, G. and Senior, J. (1980) The phospholipid component of small liposomes controls the rate of clearance of entrapped solutes from the circulation. FEBS Lett, 119, pp. 43-46.
21. Gregoriadis, G., Morell, AG, Sternlieb, I. and Scheinberg, IH (1970) Catabolism of desialylated ceruloplasmin in the liver. J Biol Chem, 245, pp. 5833-5837.
22. Gregoriadis, G., Leathwood, PD and Ryman, BE (1971) Enzyme entrapment in liposomes. FEBS Lett, 14, p. 95.
23. Gregoriadis, G., Swain, CP, Wills, EJ and Tavill, AS (1974) Drug-carrier potential of liposomes in cancer chemotherapy. Lancet, pp. 1313-1316.
24. Gregoriadis, G., Saffie, R. and de Souza, B. (1997) Liposome-mediated DNA vaccination. FEBS Lett, 402, pp. 107-110.
25. Hwang, KJ, Luke, KFS and Baumier, PL (1980) Hepatic uptake and degradation of unilamellar sphingo-myelin/cholesterol liposomes: A kinetic study. Proc Natl Acad Sci USA, 77, pp. 4030-4034.
26. Juliano, R. and Stamp, D. (1975) Effect of particle size and charge on the clearance of liposome-encapsulated drugs. Biochem Biophys Res Commun, 63, pp. 651-658.
27. Kirby, C., Clarke, J. and Gregoriadis, G. (1980) Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J, 186, pp. 591-598.
28. Klibanov, AL, Marnyama, K., Torchilin, VP and Huang, L. (1990) Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett, 268, pp. 235-237.
29. Leserman, L. (2004) Liposomes as protein carriers in immunology. J Liposome Res, 14, pp. 175-189.
30. Morell, A., Gregoriadis, G., Scheinberg, IH, Hickman, J. and Ashwell, G. (1971) The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem, 246, pp. 1461-1467.
31. O'Neil, GJ (1979) The use of antibodies as drug carriers. Drug carriers in biology and medicine, pp. 23-41. Academic Press, London
32. Papahadjopoulos, D. (1978) Liposomes and their uses in biology and medicine. NY Acad Sci, 308, pp. 1-462.
33. Papahadjopoulos, D., Allen, T., Gabizon, A., Mayhew, E., Matthay, K., Huang, K., Lee, SK, Woodle, MC, Lasic, DD, Redemann, C. and Martin, FJ (1991) Sterically stabilized liposomes: Improvements in pharmacokinetics, tissue disposition and anti-tumour therapeutic efficacy. Proc Natl Acad Sci USA, 88, pp. 11460-11464.
34. Perrie, Y., Frederik, PM and Gregoriadis, G. (2001) Liposome-mediated DNA vaccination: The effect of vesicle composition. Vaccine, 19, pp. 3301-3310.
35. Senior, JH and Gregoriadis, G. (1982) Is half-life of circulating small unilamellar liposomes determined by changes in their permeability?. FEBS Lett, 145, pp. 109-114.
36. Senior, JH, Delgado, C., Fisher, D., Tilcock, C. and Gregoriadis, G. (1991) Influence of surface hydrophilicity of liposomes on their interaction with plasma proteins and clearance from the circulation: Studies with polyethylene glycol-coated vesicles. Biochim Biophys Acta, 1062, pp. 77-82.